SHANDONG FENGYUAN CHEMICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.38 CNY | -1.98% |
|
-1.20% | -22.53% |
| 2023 | Shandong Fengyuan Chemical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
| 2023 | Shandong Fengyuan Chemical Co., Ltd. Approves Executive Changes | CI |
| Sales 2021 | 803M 111M 9.24B | Sales 2022 | 1.74B 240M 19.97B | Capitalization | 8.11B 1.12B 93.27B |
|---|---|---|---|---|---|
| Net income 2021 | 53M 7.31M 610M | Net income 2022 | 151M 20.84M 1.74B | EV / Sales 2021 | 6.83 x |
| Net cash position 2021 | 128M 17.61M 1.47B | Net Debt 2022 | 625M 86.31M 7.2B | EV / Sales 2022 | 5.03 x |
| P/E ratio 2021 |
95.6
x | P/E ratio 2022 |
49.4
x | Employees | 756 |
| Yield 2021 |
0.09% | Yield 2022 |
0.25% | Free-Float | 61.57% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.98% | ||
| 1 week | -1.20% | ||
| Current month | -2.67% | ||
| 1 month | -2.90% | ||
| 3 months | -12.94% | ||
| 6 months | -31.72% | ||
| Current year | -22.53% |
1 week
11.71
13.22
1 month
11.7118.22
Current year
8.6018.22
1 year
8.6023.21
3 years
8.6052.96
5 years
7.5152.96
10 years
3.3152.96
| Managers | Title | Age | Since |
|---|---|---|---|
Yan Deng
CEO | Chief Executive Officer | 47 | 01/02/01 |
Lin Pang
DFI | Director of Finance/CFO | 50 | 01/22/01 |
Guichen Li
CHM | Chairman | 50 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jian Li
BRD | Director/Board Member | 45 | 15/23/15 |
Fu Xin Mo
BRD | Director/Board Member | 56 | 01/04/01 |
Yan Deng
CEO | Chief Executive Officer | 47 | 01/02/01 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 12.38 | -1.98% | 19,832,130 |
| 25/24/25 | 12.63 | -0.71% | 24,675,880 |
| 24/24/24 | 12.72 | -1.40% | 30,843,750 |
| 23/24/23 | 12.9 | +9.97% | 12,403,070 |
| 22/24/22 | 11.73 | -6.38% | 17,835,370 |
End-of-day quote Shenzhen S.E., April 26, 2024
More quotes
Shandong Fengyuan Chemical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of industrial oxalic acid, electronic grade refined oxalic acid and oxalic acid derivative oxalate. The Company's main products include industrial oxalic acid, refined oxalic acid, sodium nitrate and oxalate. The Company's products are mainly applied in the pharmaceutical industry, rare earth industry, fine chemical industry, daily chemical industry and printing and dyeing industry. The Company is also engaged in the production and sales of cathode materials for lithium batteries. The Company mainly conducts its businesses within domestic market.
Sector
Commodity Chemicals
Calendar
30/04/2024
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -22.53% | 478M | |
| +5.14% | 103B | |
| -1.80% | 63.04B | |
| +39.52% | 39.06B | |
| +12.91% | 37.58B | |
| +7.41% | 33.26B | |
| +6.85% | 19.22B | |
| +12.86% | 16.83B | |
| +7.73% | 15.03B | |
| +16.93% | 14.96B |
- Stock Market
- Equities
- 002805 Stock
